Financhill
Sell
37

RMD Quote, Financials, Valuation and Earnings

Last price:
$244.59
Seasonality move :
2.62%
Day range:
$244.09 - $245.46
52-week range:
$199.92 - $293.81
Dividend yield:
0.93%
P/E ratio:
25.02x
P/S ratio:
6.84x
P/B ratio:
5.83x
Volume:
201.3K
Avg. volume:
992.2K
1-year change:
5.1%
Market cap:
$35.7B
Revenue:
$5.1B
EPS (TTM):
$9.77

Earnings Data

Next earnings date for RMD
Feb 05
2026
Most recent earnings per share
$2.37
Missed by $0.13
(Oct 30/2025)
Consensus Estimate
$2.50
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 $1.4B -- -- $2.71 --
10/30/2025 Q3 $1.3B $1.3B $2.37 $2.50 -$0.13
07/31/2025 Q2 $1.3B $1.3B $2.58 $2.48 $0.10
04/23/2025 Q1 $1.3B $1.3B $2.48 $2.36 $0.12
01/30/2025 Q4 $1.3B $1.3B $2.34 $2.31 $0.02
10/24/2024 Q3 $1.2B $1.2B $2.11 $2.04 $0.07
08/01/2024 Q2 $1.2B $1.2B $1.98 $2.07 -$0.09
04/25/2024 Q1 $1.2B $1.2B $2.04 $1.91 $0.13
01/24/2024 Q4 $1.2B $1.2B $1.42 $1.78 -$0.37
10/26/2023 Q3 -- $1.1B $1.49 -- --
08/03/2023 Q2 -- $1.1B $1.56 -- --
04/27/2023 Q1 -- $1.1B $1.58 -- --
01/26/2023 Q4 -- $1B $1.53 -- --
10/27/2022 Q3 -- $950.3M $1.43 -- --
08/11/2022 Q2 -- $914.7M $1.33 -- --
04/28/2022 Q1 -- $864.5M $1.22 -- --
01/27/2022 Q4 -- $894.9M $1.37 -- --
10/28/2021 Q3 -- $904M $1.39 -- --
08/05/2021 Q2 -- $876.1M $1.33 -- --
04/29/2021 Q1 -- $768.8M -$0.54 -- --
01/28/2021 Q4 -- $800M $1.23 -- --
10/29/2020 Q3 -- $751.9M $1.22 -- --
08/05/2020 Q2 -- $770.3M $1.22 -- --
04/30/2020 Q1 -- $769.5M $1.12 -- --
01/30/2020 Q4 -- $736.2M $1.10 -- --
10/24/2019 Q3 -- $681.1M $0.83 -- --
07/25/2019 Q2 -- $705M $0.48 -- --
05/02/2019 Q1 -- $662.2M $0.73 -- --
01/24/2019 Q4 -- $651.1M $0.86 -- --
10/25/2018 Q3 -- $588.3M $0.73 -- --
08/02/2018 Q2 -- $623.6M $0.76 -- --
04/26/2018 Q1 -- $591.6M $0.76 -- --
01/22/2018 Q4 -- $601.3M $0.07 -- --
10/26/2017 Q3 -- $523.7M $0.60 -- --
08/01/2017 Q2 -- $556.7M $0.71 -- --
04/27/2017 Q1 -- $514.2M $0.62 -- --
01/23/2017 Q4 -- $530.4M $0.54 -- --
10/25/2016 Q3 -- $465.5M $0.54 -- --
07/28/2016 Q2 -- $518.6M $0.59 -- --
04/26/2016 Q1 -- $453.9M $0.64 -- --
01/21/2016 Q4 -- $454.5M $0.68 -- --

ResMed, Inc. Earnings Questions

  • How Much did ResMed, Inc. Generate in Revenue Last Quarter?

    ResMed, Inc. reported $1.3B worth of top line sales in its most recent quarter.

  • Did ResMed, Inc. Beat Earnings Last Quarter?

    ResMed, Inc. announced earnings per share of $2.37 which represents a miss of analyst forecast a $2.50 per share.

  • Is ResMed, Inc. Profitable?

    ResMed, Inc. reported $808.9M that represents $5.51 per share over the last quarter.

  • What is the Analyst Consensus for ResMed, Inc. EPS Next Year?

    ResMed, Inc.'s earnings are forecast to grow from $9.51 per share to $9.50 per share next year representing an increase of 14.71%.

  • When is ResMed, Inc.'s Earnings Date?

    ResMed, Inc.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock